News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024April 11, 2025 InhaleRx has received Human Research Ethics Committee (HREC) approval to start a Phase II clinical trial […]
US FDA rejects Neurotech application for orphan drug status by Steve Jones October 8, 2024February 25, 2025
Neurotech seeks pharma partners for overseas drug development but will go it alone in Australia by Steve Jones August 12, 2024August 12, 2024
Cannabinoid drug developer holds ‘positive’ talks with TGA as hopes rise of fast-tracking ARTG listing by Steve Jones June 28, 2024June 28, 2024
Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities by Steve Jones April 17, 2024April 18, 2024
Neurotech reports positive results from latest trial of cannabinoid drug candidate NTI164 by Martin Lane October 6, 2023April 30, 2024
Company news: ANTG; Avecho; Canopy Growth; Zelira/Levin Health; Neurotech; Epsilon; Creso Pharma by cannabiz team December 9, 2021April 29, 2024
